Skip to main content

Table 1 Relationship between clinicopathological features and F-PLR score in ESCC

From: Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma

Variable

F-PLR score

0(%)

1(%)

2(%)

p

Age(y)

   

0.345

 <60

91 (46.9)

83 (39.7)

44 (42.7)

 

 ≥60

103 (53.1)

126 (60.3)

59 (57.3)

 

Gender

   

0.791

 Male

159 (82.0)

168 (80.4)

86 (83.5)

 

 Female

35 (18.0)

41 (19.6)

17 (16.5)

 

Tumor location

   

0.207

 Upper

26 (8.0)

12 (6.6)

38 (7.5)

 

 Middle

200 (61.7)

101 (55.5)

301 (59.5)

 

 Lower

98 (30.2)

69 (37.9)

167 (33.3)

 

Tumor length (cm)

   

< 0.001

 <3.5

94 (48.5)

73 (34.9)

24 (23.3)

 

 ≥3.5

100 (51.5)

136 (65.1)

79 (76.7)

 

Differentiation

   

0.804

 Well - moderate

150 (77.3)

163 (78.0)

83 (80.6)

 

 Poor

44 (22.7)

46 (22.0)

20 (19.4)

 

Depth of tumor invasion

   

0.001

 T1-2

82 (42.3)

67 (32.1)

22 (21.4)

 

 T3-4

112 (57.7)

142 (67.9)

81 (78.6)

 

Lymph node metastasis

   

0.074

 N0

114 (58.8)

101 (48.3)

60 (58.3)

 

 N1-3

80 (41.2)

108 (51.7)

43 (41.7)

 

TNM stage

   

0.152

 I-II

82 (42.3)

69 (33.0)

37 (35.9)

 

 III-IV

112 (57.7)

140 (67.0)

66 (64.1)

 

Adjuvant chemotherapy

   

0.789

 Yes

79 (40.7)

90 (43.1)

46 (44.7)

 

 No

115 (59.3)

119 (56.9)

57 (55.3)

 
  1. Abbreviations, F-PLR score: fibrinogen and platelet-lymphocyte ratio score
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us